Industry Collaborations Can Save Time, Boost Profits on Cancer Drugs, FDA Official Says

Drug sponsors should look to their peers as potential partners, not as competitors, if they want to create a more effective and efficient path to cancer drug discovery, CDER Director Janet Woodcock advises.
Drug Industry Daily